FDA Grants Breakthrough Therapy Designation For Pfizer's RSVpreF To Prevent RSV In Infants
2/3 13:47
(RTTNews) - Pharma major, Pfizer Inc. (PFE) said on Wednesday that the US Food and Drug Administration or FDA has provided Breakthrough Therapy Designation for its maternal Respiratory Syncytial Virus or RSV vaccine candidate or RSVpreF....